Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis: A better response in male patients

Modern Rheumatology

Volumn 14, Issue 6, 2004, Pages 442-446

  Kameda, Hideto ^a   Amano, Koichi ^a   Sekiguchi, Naoya ^a   Takei, Hirofumi ^a   Ogawa, Hiroe ^a   Nagasawa, Hayato ^a   Takeuchi, Tsutomu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bucillamine; Disease modifying antirheumatic drug (DMARD); Methotrexate (MTX); Outcome; Remission

Indexed keywords

ACTARIT; AZATHIOPRINE; BUCILLAMINE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; GENDER; HUMAN; JAPAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; WESTERN HEMISPHERE;

EID: 11144276683     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-004-0340-3     Document Type: Article

References (14)

1. Furst DE. The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases. Br J Rheumatol 1997;36:1196-204.
2. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis. 2002 update. Arthritis Rheum 2002;46:328-46.
3. Pincus T, Ferraccioli G, Sokka T, Larsen A, Rau R, Kushner I, et al. Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: Updating a 1983 review. Rheumatology 2002;41:1346-56.
4. Jones G, Halbert J, Crotty M, Shanahan EM, Batterham M, Ahern M. The effect of treatment on radiological progression in rheumatoid arthritis: A systemic review of randomized placebo-controlled trials. Rheumatology 2003;42:6-13.
5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
6. Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 1985;312:818-22.
7. Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill I. Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 1989;16:313-20.
8. Barrera P, van der Maas A, van Ede AE, Kiemeney BALM, Laan RFJM, van de Putte LBA, et al. Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-α antibody compared with methotrexate in long-standing rheumatoid arthritis. Rheumatology 2002;41:430-9.
9. Dougados M, Combe B, Cantagrel A, Goupille P, Olive P, Schattenkirchner M, et al. Combination therapy in early rheumatoid arthritis: A randomized, controlled, double-blind 52-week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis 1999;58:220-5.
10. Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis. The importance of disease duration. Arthritis Rheum 2000;43:22-9.
11. Hoekstra M, van Ede AE, Haagsma CJ, van de Laar MAF, Huizinga TWJ, Kruijsen MWM, et al. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:423-6.
12. Aletaha D, Stamm T, Kapral T, Eberl G, Grisar J, Machold KP, et al. Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: A matched observational study. Ann Rheum Dis 2003;62:944-51.
13. Weinblatt ME, Maier AL, Fraser PA, Coblyn JS. Long-term prospective study of methotrexate in rheumatoid arthritis: Conclusion after 132 months of therapy. J Rheumatol 1998;25:238-42.
14. Suzuki Y, Noguchi A, Tajima C, Uehara R, Ide M, Ichikawa Y, et al. Clinical relapse of rheumatoid arthritis (escape phenomenon) during low-dose methotrexate therapy. Ryumachi 1998;38:6-13.